PF chemotherapy combined with a PD-1/CTLA-4 bispecific antibody as first-line treatment in patients with recurrent/metastatic head and neck squamous cell carcinoma: a prospective, single-arm, phase II clinical study. [PDF]
Liao W +5 more
europepmc +1 more source
Systemic Therapies in Advanced Adrenocortical Carcinoma: Current Standards, Emerging Strategies, and Practical Considerations. [PDF]
Sanchez LP +3 more
europepmc +1 more source
Comparative efficacy and safety of low dose vs. standard-dose immune checkpoint inhibitors: A systematic review and meta-analysis. [PDF]
Wu Y, Qin J, Jin X, Qian Y.
europepmc +1 more source
Evaluating the potential of candidate surrogate endpoints for overall survival in treatment-naive metastatic melanoma treated with anti-PD-1-based regimens with or without anti-CTLA-4 therapy. [PDF]
Squifflet P +6 more
europepmc +1 more source
Efficacy and safety of stereotactic body radiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis. [PDF]
Ji P +9 more
europepmc +1 more source
Bispecific antibodies targeting B-cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions. [PDF]
Manzato E +5 more
europepmc +1 more source
Evaluating taletrectinib in the treatment of patients with <i>ROS1</i> fusion-positive non-small cell lung cancer. [PDF]
Nagasaka M +7 more
europepmc +1 more source
ORR-LOYGUE OPERATION FOR RECTAL PROLAPSE
Mehmet ERDOĞAN +5 more
doaj

